|
ACIN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.786100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.389200E-04 |
| Normal-vs-Stage2 |
1.502990E-01 |
| Normal-vs-Stage3 |
7.360100E-03 |
| Normal-vs-Stage4 |
6.080400E-02 |
| Stage1-vs-Stage2 |
4.719200E-01 |
| Stage1-vs-Stage3 |
8.284400E-01 |
| Stage1-vs-Stage4 |
3.866600E-01 |
| Stage2-vs-Stage3 |
6.349400E-01 |
| Stage2-vs-Stage4 |
9.995400E-01 |
| Stage3-vs-Stage4 |
5.693400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.599400E-03 |
| Normal-vs-AfricanAmerican |
5.62039999999486E-05 |
| Normal-vs-Asian |
5.84610000409214E-08 |
| Caucasian-vs-AfricanAmerican |
8.695400E-03 |
| Caucasian-vs-Asian |
1.196520E-03 |
| AfricanAmerican-vs-Asian |
3.199900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.406340E-02 |
| Normal-vs-Female |
2.81109999999973E-06 |
| Male-vs-Female |
8.383300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.314000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.642910E-04 |
| Normal-vs-Age(61-80Yrs) |
6.104500E-03 |
| Normal-vs-Age(81-100Yrs) |
9.302000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.878400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.039600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.883810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.322800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.014610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.450400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.17919995568894E-09 |
| Normal-vs-Grade 2 |
5.955900E-04 |
| Normal-vs-Grade 3 |
1.625820E-02 |
| Normal-vs-Grade 4 |
2.783700E-02 |
| Grade 1-vs-Grade 2 |
3.575100E-03 |
| Grade 1-vs-Grade 3 |
7.616200E-04 |
| Grade 1-vs-Grade 4 |
4.185000E-04 |
| Grade 2-vs-Grade 3 |
2.730200E-01 |
| Grade 2-vs-Grade 4 |
8.177000E-01 |
| Grade 3-vs-Grade 4 |
5.854800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.825400E-04 |
| Normal-vs-ccB subtype |
3.255800E-02 |
| ccA subtype-vs-ccB subtype |
4.169200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.376400E-03 |
| Normal-vs-N1 |
6.311200E-01 |
| N0-vs-N1 |
4.525600E-01 |
|
|
